Didem Aral built a solid professional foundation through experience across various roles within the marketing and creative industry. She is currently the founder and CEO of reprai, a technology initiative focused on supporting pharmaceutical and healthcare organizations through AI-powered solutions for healthcare communications.

She has accumulated nearly 25 years of experience in the marketing and creative industry, particularly within healthcare and regulated sectors, with a career shaped by a diverse portfolio of projects across both traditional and digital platforms. Her professional journey includes long-term collaboration and strategic partnerships with well-established global brands.

She joined Horizon Marketing Solutions Agency as a Managing Partner in 2004, where she led the agency’s creative vision and growth initiatives. Under her leadership, Horizon evolved from a local agency into a globally operating organization with offices in Amsterdam, Istanbul and London.
Alongside her professional work, she has a strong interest in health and healthcare communications, through which she has developed deep expertise in medico-marketing.

She has supported a wide range of go-to-market strategies, product launches, and healthcare professional communication initiatives for leading pharmaceutical and healthcare companies, including Pfizer, Johnson & Johnson, MSD, Merck, Novo Nordisk, Takeda, and Bayer.

In 2022, she co-founded a health technology venture providing 24/7 primary healthcare services for immigrant communities. The venture received investment support from a corporate venture capital firm with a focus on impact-driven initiatives.

She is currently the founder and CEO of reprai, a technology initiative focused on supporting pharmaceutical and healthcare organizations through AI-powered solutions for healthcare communications, designed to enable more effective and efficient engagement with healthcare professionals.

She is an active advocate for women’s entrepreneurship and currently serves as an advisor on the Advisory Council of WeConnect.